18 of 114 unique stocks in common · Jaccard: 15.8%
A weighted portfolio overlap of 32.92% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹32.92 is allocated to the exact same companies at the same relative proportions. The schemes share 18 common holdings.
The largest overlapping asset in their portfolios is ICICI Bank, which commands a weight of 8.26% in Aditya Birla Sun Life ESG Integration Strategy Fund and 8.94% in SBI ELSS Tax Saver Fund. Holding both schemes increases your concentration in ICICI Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in SBI |
|---|---|---|
| ICICI BankBanks | 8.26% | 8.94% |
| Kotak Mahindra BankBanks | 3.72% | 5.93% |
| State Bank of IndiaBanks | 3.23% | 3.62% |
| HDFC BankBanks | 4.60% | 2.91% |
| Tata Consultancy ServicesIT - Software | 2.19% | 2.08% |
| Axis BankBanks | 3.68% | 1.86% |
| Bharti AirtelTelecom - Services | 4.15% | 1.81% |
| Hindalco IndustriesNon - Ferrous Metals | 2.75% | 1.80% |
| InfosysIT - Software | 3.56% | 1.00% |
| Tech MahindraIT - Software | 0.93% | 1.81% |
| LupinPharmaceuticals & Biotechnology | 0.81% | 1.97% |
| Mahindra & MahindraAutomobiles | 2.24% | 0.80% |
| Britannia IndustriesFood Products | 1.21% | 0.79% |
| Bajaj FinanceFinance | 2.43% | 0.74% |
| Godrej Consumer ProductsPersonal Products | 0.94% | 0.67% |
| CiplaPharmaceuticals & Biotechnology | 0.62% | 2.15% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 0.93% | 0.55% |
| Pitti EngineeringIndustrial Manufacturing | 0.57% | 0.33% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.